Stocks and Investing Stocks and Investing
Tue, August 13, 2024

Gregory Renza Reiterated (SPRB) at Hold and Held Target at $2 on, Aug 13th, 2024


Published on 2024-10-28 13:35:47 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Reiterated "Spruce Biosciences, Inc." (SPRB) at Hold and Held Target at $2 on, Aug 13th, 2024.

Gregory has made no other calls on SPRB in the last 4 months.



There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 1 agrees with Gregory's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Hold on, Wednesday, June 5th, 2024


This is the rating of the analyst that currently disagrees with Gregory


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $3 on, Thursday, June 13th, 2024
Contributing Sources